HTE is a field of chemistry that expanded exponentially in the past five years, and most pharmaceutical companies are currently using it in their workflows. This methodology allows multi-parameter optimisation of chemical reactions but also synthesis of multiple compounds (96 to 384) on a small-scale using plate chemistry. Combined with the implementation of Direct-to-Biology (D2B) approaches, which involves the direct testing of non-purified mixtures, biological data is obtained faster. The combination of these methods greatly improves the Design, Make, Test, and Analyse (DMTA) cycle.

The option is a cloud-based design platform, accessible via a secure web interface, offering enhanced scalability and reduced infrastructure overhead. The solution will integrate with a University of Dundee-hosted virtual machine to enable secure data exchange and computational workflows. Installation of server-side components will be managed by the DDU Data Management and Computational Chemistry teams, with network provisioning supported by DTS. Ongoing maintenance and updates will be provided by the vendor.